TopQ Cut-off Score Validation Study for 3D OCT-1 Maestro

NCT02447133 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2022-06-29

Study results available
· View outcomes & findings →

Summary

The objective of this study is to validate the TopQ cutoff scores, which have been previously determined.

Conditions

  • Subjects Presenting With Normal Eyes

Interventions

DEVICE

3D OCT-1 Maestro

OCT Machine used for diagnostic purposes

Sponsors & Collaborators

  • Topcon Medical Systems, Inc.

    lead INDUSTRY

Principal Investigators

  • Randy Sun, MD · Topcon Corporation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02447133 on ClinicalTrials.gov